2024年10月24日 · CDC recommends meningococcal vaccination for all adolescents. CDC also recommends meningococcal vaccination for children and adults at increased risk for meningococcal disease. Follow the recommended immunization schedule to ensure that your patients get the meningococcal vaccines that they need.

2022年10月3日 · The meningococcal conjugate vaccine or MCV4 was approved in 2005. It uses antigens taken from the polysaccharide capsule and then bound to a separate protein that targets the body's immune cells.

CDC recommends meningococcal vaccination for all preteens and teens, as well as other children and adults at increased risk. Meningococcal vaccines are the best way to protect against meningococcal disease, but side effects can occur. Talk to a vaccine provider if you have questions about meningococcal vaccines.

2024年10月24日 · There are 5 meningococcal vaccines available in the United States. Meningococcal vaccines help protect against one serogroup (strain) or multiple serogroups of the bacteria that cause meningococcal disease. Meningococcal vaccines help protect those who get vaccinated, but protection decreases over time.

In June 2012, the FDA approved a combination vaccine against two types of meningococcal disease and Hib disease for infants and children 6 weeks to 18 months old. The vaccine, Menhibrix, prevents disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type b.

2024年2月6日 · Vaccines can help prevent meningococcal disease. There are 3 types of meningococcal vaccines available in the United States: All adolescents ages 11–12, with a booster dose at 16 years.

The quadrivalent conjugate meningococcal vaccine is a routine childhood vaccination given to adolescents, preferably at age 11 or 12 years, with a booster dose at age 16 years (see CDC: Child and Adolescent Immunization Schedule by Age). It is also recommended for younger children who are at high risk of infection.

2024年12月25日 · Meningococcal conjugate vaccine is used to prevent infection caused by serogroups A, C, W, and Y. This vaccine helps your body develop immunity to meningitis, but will not treat an active infection you already have.

2024年12月12日 · All adolescents 11-18 years of age without contraindications should receive meningococcal conjugate vaccine (abbreviations: MCV4, MenACWY; trade names: Menactra®, Menveo®), routinely given at 11 or 12 years of age with a booster at 16 years of age.

2024年5月28日 · WebMD explains the meningococcal vaccine for adults, including who should get it, why, and possible side effects.